Purinergic regulation of the immune system
Nature Reviews Immunology
Nature Publishing Group
177 - 192
Item Usage Stats
Cellular stress or apoptosis triggers the release of ATP, ADP and other nucleotides into the extracellular space. Extracellular nucleotides function as autocrine and paracrine signalling molecules by activating cell-surface P2 purinergic receptors that elicit pro-inflammatory immune responses. Over time, extracellular nucleotides are metabolized to adenosine, leading to reduced P2 signalling and increased signalling through anti-inflammatory adenosine (P1 purinergic) receptors. Here, we review how local purinergic signalling changes over time during tissue responses to injury or disease, and we discuss the potential of targeting purinergic signalling pathways for the immunotherapeutic treatment of ischaemia, organ transplantation, autoimmunity or cancer.
Adenosine A2 receptor
Adenosine A2b receptor
Purinergic P2 receptor
Purinergic P2X receptor
Purinergic P2Y receptor
Heart muscle ischemia
Natural killer T cell
Regulatory T lymphocyte
Published Version (Please cite this version)https://doi.org/10.1038/nri.2016.4
Showing items related by title, author, creator and subject.
Myeloid expression of adenosine a2A receptor suppresses T and NK cell responses in the solid tumor microenvironment Cekic, C.; Day, Y.-J.; Sag, D.; Linden J. (American Association for Cancer Research Inc., 2014)High concentrations of adenosine in tumor microenvironments inhibit antitumor cytotoxic lymphocyte responses. Although T cells express inhibitory adenosine A2A receptors (A2AR) that suppress their activation and inhibit ...
Tincer G.; Bayyurt, B.; Arıca, Y.M.; Gürsel İ. (Turkish Society of Immunology, 2015)Objectives: Chitosan is a widely used vaccine or anti-cancer delivery vehicle. In this study, we investigated the immunomodulatory effect of chitosan/pIC nanocomplexes on mouse immune cells. Materials and methods: Proliferative ...
Impaired toll like receptor-7 and 9 induced immune activation in chronic spinal cord injured patients contributes to immune dysfunction Gucluler, G.; Adiguzel, E.; Gungor, B.; Kahraman, T.; Gursel, M.; Yilmaz, B.; Gursel, I. (Public Library of Science, 2017)Reduced immune activation or immunosuppression is seen in patients withneurological diseases. Urinary and respiratory infections mainly manifested as septicemia and pneumonia are the most frequent complications following ...